Home » Topics » BioWorld Science

BioWorld Science
RSS

Alpha Cognition signs up CRO to support development of Alpha-1062 for Alzheimer's

April 23, 2020

GRP78 does not predict bortezomib response in patients with multiple myeloma

April 23, 2020

Polymer-linked rotigotine shows promise in patients with PD

April 23, 2020

Cheating cell death improves post-infarct heart function

April 23, 2020

Truncating DNVs in the last exon of SEMA6B causes progressive myoclonic epilepsy

April 23, 2020

Positive data presented from phase III SPIRIT 2 study of relugolix combination therapy

April 23, 2020

Phase II study of vixarelimab in prurigo nodularis meets primary efficacy endpoint

April 23, 2020

Updates presented for phase II PASADENA study of prasinezumab

April 23, 2020

CCL5 expression is regulated by two distinct enhancers during inflammation vs. homeostasis

April 23, 2020

German approval for phase I/II trial of BNT-162 vaccine program to prevent COVID-19

April 23, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...